Procter & Gamble Company (The)(PG) - Stock detail

Procter & Gamble Company (The)

US
PG
The Procter & Gamble Company(Listing date: 03/22/1950)

Procter & Gamble was incorporated in Ohio in 1905. The company is a global leader in the fast-moving consumer goods industry, focused on providing high-quality and valuable branded consumer packaged goods to consumers around the world. Its products are sold in more than 180 countries and regions primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, pharmacies, department stores, distributors, wholesalers, baby stores, professional beauty stores (including airport duty-free stores), high-frequency stores, electronics stores and professional channels. The company also sells products directly to consumers.

AI Trading DecisionHold
Generated at:2026-04-17 17:46:43
Analysis data includes fundamental valuation metrics (P/E ratio, revenue growth, net margins, profitability metrics), technical indicators (moving averages, MACD, RSI, Williams %R), catalyst analysis (Q3 FY2026 earnings, analyst targets), and risk/reward assessment. Data time range includes current price as of report generation and 3-month target horizon.
Summary

Trading strategy overview: Target price is $148.00, stop-loss price is $141.00, confidence level is 0.65, risk score is 0.55. The recommendation is to hold PG stock as it represents a high-quality defensive holding trading near fair value with an imminent earnings catalyst creating asymmetric risk. The $148.00 target price represents a technical midpoint between support and resistance, alignment with chip distribution, fundamental fair value adjustment, earnings catalyst incorporation, and time horizon consideration.

Operation strategy
  • For existing holders: Selling at current levels locks in losses after 13% correction from February highs. The dividend yield (~3%) provides compensation during volatility. Technical indicators suggest potential stabilization above $144 support.
  • For potential buyers: Current entry is suboptimal due to overbought short-term conditions and pre-earnings uncertainty. Better entry would be post-earnings sell-off toward $138-$142 support or break above $152 resistance on sustained volume.
  • Portfolio context: PG serves as defensive, income-generating component. In uncertain markets, its non-discretionary product portfolio provides stability despite modest growth prospects.
  • Monitoring triggers: Upgrade to BUY if stock declines to $138-$142 post-earnings with stabilization. Downgrade to SELL if breaks below $141 support on closing basis. Accumulate signal: Sustained move above $152 with volume confirmation.

Core Support

Reasoning summary
  • Fundamental Valuation Context: Current price: $146.93 vs. calculated fair value range of $129.40-$155.28 (midpoint $142.34). Trading at ~22x P/E with 2.24% revenue growth and 20.43% net margins. Strong profitability metrics (ROE: 17.27%, ROA: 7.18%) justify premium valuation. Dividend aristocrat with 70th consecutive annual increase (3% to $1.0885 quarterly).
  • Technical Position: Recent breakout above short-term MAs (5, 10, 20-day) on April 17 with increased volume. Bullish MACD crossover signal (histogram: +0.6162). However, short-term indicators show overbought conditions (6-period RSI: 64.80, Williams %R: -9.64). Primary trend remains down with 60-day SMA at $151.96 above current price. Key support: $141-$144 zone; Key resistance: $150-$152 then $157-$160.
  • Catalyst Analysis: Imminent Q3 FY2026 earnings (week of April 20) creates asymmetric risk. Analyst sentiment cautious with multiple target reductions (Piper Sandler: $142, RBC: $167). News analysis suggests post-earnings range: -8% to +6% ($135-$156). Dividend increase provides downside support but doesn't address near-term earnings risk.
  • Risk/Reward Assessment: Downside risk to $138-$142 (8-10%) if earnings disappoint. Upside potential to $152-$157 (4-7%) if earnings beat. Current position offers unfavorable risk/reward ahead of earnings catalyst. However, long-term quality and defensive characteristics warrant holding rather than selling.
  • Target Price Justification: The $148.00 3-month target price represents technical midpoint between immediate support ($142) and resistance ($152), alignment with chip distribution - upper bound of 70% concentration range is $157.31, fundamental fair value adjustment - midpoint of $142.34 fair value with modest premium for quality, earnings catalyst incorporation - assumes earnings meet expectations without major surprises, and time horizon consideration - 3-month period allows for post-earnings volatility to settle.